Get the Stockscreener App
19.66
0.31%
0.06
After Hours:
19.66
Singular Genomics Systems Inc stock is traded at $19.66, with a volume of 30,220.
It is up +0.31% in the last 24 hours and down -8.34% over the past month.
Singular Genomics Systems Inc is a life science technology company that is leveraging novel next generation sequencing and multiomics technologies to build products that empower researchers and clinicians. The product development pipeline comprises two initial integrated solutions, each designed to leverage Sequencing Engine and purpose built to address different applications. The G4 Sequencing Platform is designed to target the NGS market. The PX Integrated Solution is designed to target the single cell, spatial analysis and proteomics markets. Both integrated solutions are used in many different and diverse market segments, including basic biology, oncology, immunology, neurology, genetic diseases, infectious diseases, the human microbiome and many others.
See More
Previous Close:
$19.60
Open:
$19.62
24h Volume:
30,220
Relative Volume:
1.23
Market Cap:
$49.81M
Revenue:
$2.91M
Net Income/Loss:
$-94.82M
P/E Ratio:
-15.12
EPS:
-1.3
Net Cash Flow:
$-74.62M
1W Performance:
+0.31%
1M Performance:
-8.34%
6M Performance:
+133.77%
1Y Performance:
+32.93%
1-Day Range:
$19.40
$19.80
1-Week Range:
$19.25
$20.00
52-Week Range:
$5.34
$23.41
Singular Genomics Systems Inc Stock (OMIC) Company Profile
Name
Singular Genomics Systems Inc
Sector
Industry
Phone
(858) 333-7830
Address
3010 SCIENCE PARK ROAD, SAN DIEGO
Compare OMIC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OMIC
Singular Genomics Systems Inc
|
19.66 | 49.81M | 2.91M | -94.82M | -74.62M | -1.30 |
|
ISRG
Intuitive Surgical Inc
|
535.29 | 190.66B | 7.87B | 2.24B | 586.00M | 6.22 |
|
BDX
Becton Dickinson Co
|
228.46 | 66.26B | 20.18B | 1.71B | 3.07B | 5.94 |
|
ALC
Alcon Inc
|
84.06 | 41.58B | 9.76B | 1.16B | 665.00M | 2.34 |
|
RMD
Resmed Inc
|
231.67 | 34.01B | 4.81B | 1.11B | 1.35B | 7.55 |
|
WST
West Pharmaceutical Services Inc
|
335.56 | 24.30B | 2.88B | 499.60M | 321.60M | 6.74 |
Singular Genomics Systems Inc Stock (OMIC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-17-22 | Downgrade | UBS | Buy → Neutral |
| Aug-10-22 | Downgrade | BofA Securities | Buy → Underperform |
| Aug-10-22 | Downgrade | Goldman | Buy → Neutral |
| Jan-07-22 | Upgrade | BofA Securities | Neutral → Buy |
| Oct-15-21 | Resumed | Cowen | Outperform |
Singular Genomics Systems Inc Stock (OMIC) Latest News
$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating the Merger – NEUE, OMIC, JWN, DESP - GlobeNewswire Inc.
$TOCKHOLDER ALERT: The M&A Class Action Firm Is Investigating the MergerNEUE, OMIC, JWN, DESP - Markets Insider
$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Singular Genomics Systems, Inc.OMIC - The Malaysian Reserve
$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Me - GuruFocus.com
Singular Genomics to be acquired by Deerfield for $20.00 per share in case - Yahoo Finance
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VOXX, JWN, OMIC, LTRPA on Behalf of Shareholders - The Eastern Progress Online
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RVNC, USAP, NBR on Behalf of Shareholders - cnhinews.com
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AVTE, STAF, ALVR on Behalf of Shareholders - cnhinews.com
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PDCO, NURO, PWOD, CARA on Behalf of Shareholders - cnhinews.com
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Singular Genomics Systems, Inc. (NasdaqOMIC), Nordstrom, Inc. (NYSEJWN), Despegar.com, Corp. (NYSEDESP), Patterson Companies, Inc. (Nasdaq - GlobeNewswire Inc.
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations - The Bakersfield Californian
OMIC Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Singular Genomics Systems, Inc. Is Fair to Shareholders - Business Wire
Shareholder Alert: Ademi LLP Investigates Whether Singular Genomics Systems, Inc. is Obtaining a Fair Price for Its Public Shareholders - Business Wire
Singular Genomics Systems Agrees to Be Acquired By Deerfield Management for $20 per Share - Marketscreener.com
Deerfield to Take Singular Genomics Private in $50.2M Deal - MarketWatch
Singular Genomics Enters into Agreement to be Acquired by Deerfield for $20.00 in Cash per Share - The Manila Times
Singular Genomics Agrees to $20/Share BuyoutDeerfield Offers Massive 254% Premium in Take-Private Deal - StockTitan
(OMIC) Technical Data - Stock Traders Daily
Singular genomics CEO sells stock for $3,629 By Investing.com - Investing.com South Africa
Singular genomics CEO sells stock for $3,629 - Investing.com India
Trading (OMIC) With Integrated Risk Controls - Stock Traders Daily
Singular Genomics Systems (NASDAQ:OMIC) Trading Up 3.2%What's Next? - MarketBeat
Singular Genomics Systems (NASDAQ:OMIC) Stock Price Up 3.2% – Still a Buy? - Defense World
Lumos Pharma enters into definitive merger agreement with Double Point Ventures to go private via tender offer - substack.com
(OMIC) Investment Report - Stock Traders Daily
OMICSingular Genomics Systems, Inc. Latest Stock News & Market Updates - StockTitan
Genomic Testing Market Poised to Reach Valuation of US$ 32.95 Billion By 2032 | Astute Analytica - GlobeNewswire
CRCM LP Reduces Stake in Singular Genomics Systems Inc - GuruFocus.com
(OMIC) Trading Advice - Stock Traders Daily
Short Interest in Singular Genomics Systems, Inc. (NASDAQ:OMIC) Drops By 18.9% - MarketBeat
Singular Genomics CEO Andrew Spaventa sells $15,668 in stock - Investing.com India
Singular Genomics Systems, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Singular Genomics CEO Andrew Spaventa sells $15,668 in stock By Investing.com - Investing.com Canada
Sparkline Intangible Value ETF (NYSEARCA:ITAN) Stock Price Down 0.5% – Time to Sell? - Defense World
Gusbourne (OTCMKTS:SLLFF) Stock Price Down 19.6% – Here’s Why - Defense World
Singular Genomics Systems (NASDAQ:OMIC) Trading Up 0.4%Here's Why - MarketBeat
Similar Genomics Systems: Q3 Earnings Snapshot - The Washington Post
Singular Genomics Reports Recent Updates and Third Quarter 2024 Financial Results - The Manila Times
Singular Genomics Reports Mixed Q3: Ships First G4X Amid $16.8M Loss, Strong Cash Position | OMIC Stock News - StockTitan
Singular Genomics Systems (OMIC) Earnings Date and Reports 2024 - MarketBeat
Next Generation Sequencers (NGS) Market Set to Surge at - GlobeNewswire
(OMIC) On The My Stocks Page - Stock Traders Daily
CRCM LP Acquires New Stake in Singular Genomics Systems Inc - GuruFocus.com
Spatial Genomics and Transcriptomics Market Analysis, - GlobeNewswire
Singular Genomics (OMIC) Surges Over 65% Following recent Acquisition Proposal from Concentra Biosciences: What Investors Need to Know - BP Journal
Singular Genomics Shares Soar After Deerfield Increases Acquisition Offer - MarketWatch
U.S. stock market: Glatfelter soars 1,106.32%, Nuwellis jumps 114.71%, and Staffing 360 Solutions rises 72.94% in significant midday market gains - Business Upturn
OMIC stock hits 52-week high at $21.31 amid robust growth - Investing.com Australia
U.S. Stock market gains: Glatfelter Corporation (GLT) surges +1,195.98%, Nuwellis, Inc. (NUWE) climbs +133.09% - Business Upturn
Singular Genomics Systems Inc Stock (OMIC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Singular Genomics Systems Inc Stock (OMIC) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Spaventa Andrew | Chief Executive Officer |
Nov 12 '24 |
Sale |
22.55 |
695 |
15,669 |
1,537 |
| TANG KEVIN | 10% Owner |
Sep 16 '24 |
Buy |
12.74 |
50,416 |
642,300 |
300,000 |
| TANG KEVIN | 10% Owner |
Sep 17 '24 |
Buy |
15.33 |
40,000 |
613,200 |
340,000 |
| TANG KEVIN | 10% Owner |
Sep 18 '24 |
Buy |
17.21 |
32,000 |
550,720 |
372,000 |
| Spaventa Andrew | Chief Executive Officer |
Sep 15 '24 |
Sale |
12.38 |
175 |
2,167 |
637 |
2.64%
0.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):